Prospective Evaluation of the Efficacy of Sirolimus (Rapamune®) in the Treatment of Severe Arteriovenous Malformations
Prospective Evaluation of the Efficacy of Sirolimus (Rapamune®) in the Treatment of Severe Arteriovenous Malformations
Recruiting · NCT02042326 · Registry updated 2026-05-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Prospective Evaluation of the Efficacy of Sirolimus (Rapamune®) in the Treatment of Severe Arteriovenous Malformations | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, arteriovenous hemangioma/malformation, cardiovascular disorder, vascular disorder, vascular malformation | Recruiting | Phase 2 | 2026-05-13 | NCT02042326 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Centre Hospitalier Universitaire, Amiens | 198 |
13 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| APHM | Marseille | France | 5 |
| APHP | Paris | France | 2 |
| CHRU Lille | Lille | France | 10 |
| CHU Amiens | Amiens | France | 7 |
| Chu Bordeaux | Bordeaux | France | 18 |
| Chu Dijon | Dijon | France | 14 |
| CHU Montpellier | Montpellier | France | 8 |
| CHU Nancy | Nancy | France | 3 |
| CHU Nice | Nice | France | 5 |
| CHU Strasbourg | Strasbourg | France | 9 |
| CHU Tours | Tours | France | 20 |
| HCL Lyon | Lyon | France | 1 |
| UCL | Brussels | Belgium | 1 |